Avelumab (anti-PD-L1)

Avelumab (anti-PD-L1) (MSB0010718C) is a fully human IgG1 monoclonal antibody that targets the protein programmed death-ligand 1 (PD-L1). Avelumab exhibits potential antibody-dependent cell-mediated cytotoxicity and is used for the treatment of several kinds of carcinoma. MW=143.8 kDa.

Price Not Available 1mg*5 Avelumab (anti-PD-L1) Supplier Page
Trivial name MSB0010718C
Catalog Number A2015
CAS# 1537032-82-8
Size 1mg*5
Supplier Page http://www.selleckchem.com/products/avelumab.html